Intuitive Surgical reports Q2 revenue up 19% to $2.89B, procedure growth 16%, non-GAAP EPS $2.80

Filed July 16, 2026 · Period ending July 16, 2026 · ~1 min read

Key Changes

• high

  Q2 revenue $2.89B (+19% YoY) driven by 16% procedure growth; da Vinci procedures +15%, Ion +36%. Non-GAAP EPS $2.80 vs $2.19 prior year.

  Exhibit 99.1 view on EDGAR →
• high

  Placed 468 da Vinci systems (246 da Vinci 5) vs 395 prior year; installed base grew 12% to 11,710 systems. Ion base +21% to 1,096 systems.

  Exhibit 99.1 view on EDGAR →
• high

  2026 guidance: da Vinci procedure growth 13.5%–15.5% (expects midpoint), non-GAAP gross margin 68.0%–69.0% including 1.0% tariff impact.

  Exhibit 99.1 view on EDGAR →